Cardiovascular disease risk in the offspring of diabetic women: the impact of the intrauterine environment by Marco, Laura J et al.
  
 
 
 
Marco, Laura J, McCloskey, Kate, Vuillermin, Peter J, Burgner, David, Said, Joanne and Ponsonby, Anne-
Louise 2012, Cardiovascular disease risk in the offspring of diabetic women: the impact of the intrauterine 
environment, Experimental diabetes research, vol. 2012, Article ID: 565160, pp. 1-10. 
 
DOI: 10.1155/2012/565160 
 
 
 
 
 
 
 
This is the published version. 
 
©2012, The Authors 
 
Reproduced by Deakin University under the terms of the Creative Commons Attribution Licence 
 
 
 
 
 
 
 
 
 
 
Available from Deakin Research Online: 
 
 
http://hdl.handle.net/10536/DRO/DU:30054893 
 
 
 
 
 
 
 
Hindawi Publishing Corporation
Experimental Diabetes Research
Volume 2012, Article ID 565160, 10 pages
doi:10.1155/2012/565160
Review Article
Cardiovascular Disease Risk in the Offspring of DiabeticWomen:
The Impact of the Intrauterine Environment
Laura J. Marco,1 Kate McCloskey,2, 3 Peter J. Vuillermin,2, 3, 4 David Burgner,2, 4
Joanne Said,1, 5 and Anne-Louise Ponsonby2, 4, 6
1 Pregnancy Research Centre, The Royal Women’s Hospital, Parkville, VIC 3052, Australia
2Murdoch Childrens Research Institute, The Royal Childrens Hospital, Parkville, VIC 3052, Australia
3Child Health Research Unit, Barwon Health, Geelong, VIC 3220, Australia
4Department of Paediatrics, The University of Melbourne, Parkville, VIC 3052, Australia
5Department of Obstetrics and Gynaecology, The University of Melbourne, Parkville, VIC 3052, Australia
6Environmental and Genetic Epidemiology Research Group, Population Health, Genes and Environment Theme,
Murdoch Childrens Research Institute, The Royal Childrens Hospital, Parkville, VIC 3052, Australia
Correspondence should be addressed to Anne-Louise Ponsonby, anne-louise.ponsonby@mcri.edu.au
Received 30 July 2012; Accepted 13 September 2012
Academic Editor: N. Cameron
Copyright © 2012 Laura J. Marco et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The incidence of gestational diabetes is increasing worldwide, exposing large numbers of infants to hyperglycaemia whilst in
utero. This exposure may have a long-term negative impact on the cardiovascular health of the oﬀspring. Novel methods to assess
cardiovascular status in the neonatal period are now available—including measuring arterial intima-media thickness and retinal
photography. These measures will allow researchers to assess the relative impact of intrauterine exposures, distinguishing these
from genetic or postnatal environmental factors. Understanding the long-term impact of the intrauterine environment should
allow the development of more eﬀective health policy and interventions to decrease the future burden of cardiovascular disease.
Initiating disease prevention aimed at the developing fetus during the antenatal period may optimise community health outcomes.
1. Introduction
The impact of the intrauterine environment on the devel-
oping child can be lifelong. Freinkel’s theory of fuel-
mediated teratogenesis hypothesised that fetal structures
may be exquisitely attuned to fine alterations in maternal fuel
economy and that these changes could have long-term eﬀects
on the metabolic functions of the oﬀspring [1].
Approximately 7% of pregnancies are complicated by
gestational diabetes mellitus (GDM) (ranging from 1 to 14%,
depending on the population studied and the diagnostic tests
employed) [2]. Increasing obesity rates mean the proportion
of pregnancies complicated by both Type 2 diabetes mellitus
(T2DM) and GDM is likely to continue to rise. Exposure
to dysglycaemia may have a long-term impact on the
developing child’s physiology, potentially programming for
an increased risk of cardiovascular disease in later life.
Here we review the early life origins of atherosclerosis and
cardiovascular disease. We examine the proposed biological
mechanisms linking maternal gestational hyperglycaemia
with cardiovascular risk in the oﬀspring of diabetic women.
We also review evidence from longitudinal studies of oﬀ-
spring of diabetic women, as well as some of the method-
ological limitations of these studies.
We discuss a number of novel methods to assess car-
diovascular risk in neonates, which will facilitate improved
mechanistic understanding of the eﬀect of in utero exposure
to diabetes mellitus. These methods focus research eﬀorts on
the fetal period as a potential window for future intervention.
If further research confirms the importance of intrauterine
exposure to hyperglycaemia, independent of genetic and
postnatal influences, eﬀorts to prevent cardiovascular disease
should shift to include a greater emphasis on interventions
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during the antenatal period and early childhood to attempt
to alter risk trajectories.
2. The Early Life Origins of Atherosclerosis
and Cardiovascular Disease
Cardiovascular disease remains one of the leading causes
of morbidity and mortality globally. In Australia, it is the
major cause of death, responsible for 37.6% of all deaths [3].
Whilst cardiovascular diseases usually manifest from middle
age onwards, the underlying atherosclerosis develops much
earlier and is often present antenatally.
Fatty streaks are present in the vasculature decades before
cardiovascular disease becomes symptomatic. Over fifty
years ago Holman referred to atherosclerosis as a “pediatric
problem” with childhood vascular changes being “that
portion of the process below the clinical horizon” [4].
Indeed, current evidence suggests that atherosclerosis and
cardiovascular risk begins in utero and is compounded by
postnatal influences. Autopsy data from fetuses and neonates
have found diﬀuse intima-media thickening in coronary
arteries from 36 weeks gestation [5]. Autopsy studies of
young people who have died from non-cardiovascular causes
have demonstrated that 15–34-year olds almost all have
flat fatty streaks in their thoracic and abdominal aortas
[6]. Autopsy data from the seminal Bogalusa Heart Study
revealed that essentially all persons aged 2–39 had fatty
streaks in their aortas [7].
3. What MechanismsMay Underlie the Link
betweenMaternal Diabetes and Increased
Cardiovascular Risk in the Offspring?
Maternal diabetes mellitus increases the risk of pregnancy
complications via a myriad of biological mechanisms.
Whilst glucose can cross the placenta, insulin cannot; hence
diabetes mellitus during pregnancy may expose the fetus
to an excessive glucose load. Fetal hyperglycaemia leads
to hyperinsulinaemia, causing increased hepatic glucose
uptake and glycogen synthesis [8]. This is associated with
accelerated fetal weight gain, predominately as increased
adiposity [9]. Macrosomic oﬀspring of diabetic women have
increased left ventricular mass and increased aortic intima-
media thickness compared to controls [10], as discussed
subsequently.
There have been several studies examining the relation-
ship between in utero exposure to maternal diabetes and the
development of risk factors for cardiovascular disease [10–
19]. The underlying biological mechanisms are likely to be
multifactorial; these children may be at risk due to metabolic
derangements, epigenetic changes, or via a direct eﬀect on
their vasculature.
A number of metabolic derangements have been
reported in oﬀspring of diabetic women. Macrosomic oﬀ-
spring of insulin-dependent diabetic women have increased
serum lipids, proatherosclerotic apolipoprotein A-I and B-
100, and lipoprotein levels at birth when compared to con-
trols [11]. This proatherosclerotic dyslipidaemic state may be
due to increased lipid synthesis in the setting of increased
substrate availability [20]. These changes may persist into
later life predisposing to development of the metabolic
syndrome, though longitudinal studies are lacking.
Animal studies demonstrate hyperinsulinism during pre-
natal development can disrupt the neuroendocrine systems
that regulate satiety. Selective inactivation of neuron specific
insulin receptor genes inmice results in increased food intake
and obesity [21]. Murine models of gestational diabetes
demonstrate elevated levels of insulin in the hypothalamus of
oﬀspring during perinatal life [22]. In adulthood these mice
develop hyperphagia, become overweight, and have impaired
glucose tolerance [23, 24]. Perinatal hyperinsulinism in the
oﬀspring of diabetic women may potentially increase future
risk of oﬀspring overweight by a similar mechanism, though
translational data are lacking. A hyperinsulinaemic state
during development may alter lifelong hormonal set points,
negatively impacting regulators of hunger and metabolism,
with a detrimental eﬀect on future cardiovascular health.
Exposure to hyperglycaemia in uteromay program future
disease risk via changes to critical developmental pathways
as a result of altered gene expression. Exposure to maternal
diabetes during pregnancy results in significantly altered
gene expression in embryos at mid-gestation in a mouse
model. Around 1% of the genes surveyed have expression
levels that are changed in diabetes-exposed embryos by
more than twofold relative to controls. Many of these are
transcription factors and DNA-binding molecules known to
aﬀect transcriptional regulation. This suggests that altered
transcriptional regulation may play a role in the response
of embryos to intrauterine exposure to diabetic conditions.
Thirty five of these genes were detected in the embryonic
cardiovascular system; hence these genes could potentially
contribute to cardiovascular pathology [25]. These results
have not been replicated in human trials.
Pax3, a gene required for neural tube closure, is also
required formigration of cardiac neural crest from the neural
tube to the heart and septation of the primitive cardiac
outflow tract into the aorta and pulmonary arteries. The
cardiac neural crest also promotes the formation of the
smooth muscle component of the tunica media, “middle
layer” of the aortic arch and its major branches [26].
Pax3 expression is significantly reduced in the embryos of
diabetic mice when compared to embryos of nondiabetic
mice. Maternal diabetes inhibits expression of Pax3 in
neuroepithelium, possibly through hyperglycemia-induced
oxidative stress [27]. This suggests that Pax3 may be an
important developmental control gene, expression of which
is disturbed in embryos of diabetic mice. These changes
could potentially contribute to future adverse cardiovascular
eﬀects on the oﬀspring.
Transient hyperglycaemia has been shown to lead to
long-lasting epigenetic changes in primary human and
bovine aortic endothelial cells in vitro, changes that persist
despite subsequent normoglycaemia. This is due to long
lasting activating epigenetic changes in the promoter of the
nuclear factor κB (NF-κB) subunit p65 in aortic endothelial
cells causing increased p65 gene expression [28]. Nuclear
factor-κB driven proinflammatory gene expression appears
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to play a major role in the pathogenesis of atherosclerosis
[29]. This data suggests that even short-term intrauterine
exposure to hyperglycaemia may have a pervasive eﬀect on
the cardiovascular system, contributing to a proinflamma-
tory phenotype in vascular smooth muscle cells.
Further evidence of epigenetic programming can be seen
in the intergenerational eﬀects of gestational diabetes. Mice
born to diabetic dams have an increased risk of obesity and
spontaneously develop gestational diabetes themselves. The
following generation is also at increased risk of impaired
glucose tolerance [23]. It is possible that similar mechanisms
operate in humans, but shared lifestyle exposures mean the
relative impact of intrauterine exposure to maternal diabetes
is diﬃcult to quantify. It is known that abnormal nutrition
in early life can influence diabetes risk in subsequent
generations [30], and exposure to hyperglycaemia due to
maternal diabetes mellitus may cause similar eﬀects.
Oﬀspring of diabetic women exhibit adverse vascular
changes that are measurable at birth. These include increased
arterial thickness and left ventricular mass [10]. The exact
mechanisms underlying these observations are unknown.
Similar changes are seen in infants aﬀected by intrauterine
growth restriction. Skilton et al. hypothesised these vessel
wall changes may result from increased sympathetic tone and
intrauterine dyslipidaemia [31].
4. Outcomes for Offspring of DiabeticWomen:
Evidence from Longitudinal Studies
Tracking health outcomes for the oﬀspring of diabetic
women has been an area of growing research activity and
provides important evidence for the long-term eﬀects of
exposure to intrauterine hyperglycaemia.
Studies of the Pima Indian population, who have a high
prevalence of T2DM, have been particularly informative.
Diabetes during pregnancy is followed bymarkedly increased
rates of oﬀspring obesity at 15–19 years [13], as well as
increased rates of T2DM in oﬀspring at age 20–24 years [12].
There is an increased risk of T2DM in oﬀspring of diabetic
womenwhen compared to their siblings whowere born prior
to their mother’s diagnosis of diabetes (odds ratio of T2DM
3.7, 95% CI 1.3–11.3) [16]. This suggests that exposure to
a hyperglycaemic intrauterine environment has a negative
health impact on the oﬀspring above and beyond the eﬀect of
other temporally stable characteristics of these mothers, such
as genetics or lifestyle choices. However, the Pima Indians
have one of the highest rates of T2DM in the world [32],
and hence their results may not be generalisable to other
populations.
A prospective cohort study in Sweden followed 280,866
singleton men, 1475 of whom were born after a pregnancy
complicated by diabetes mellitus. Maternal diabetes was
associated with greater mean body mass index (BMI) in
male oﬀspring at age 18 years. This large cohort allowed
comparison between siblings born before and after their
mother’s diagnosis of diabetes. BMI was 0.89 kg/m2 (95% CI
0.31–1.47) greater at age 18 years in the sibling exposed to
diabetes in utero [17]. These findings suggest that the increase
in BMI is unlikely to be due to shared lifestyle or genetic
factors and that it is intrauterine exposure to hyperglycaemia
that is largely responsible for the increased risk of subsequent
overweight.
A recent systematic review and meta-analysis examined
oﬀspring BMI z-score in childhood in relation to maternal
diabetes. Analysis of data from nine studies of diverse
populations showed that mean oﬀspring BMI z-score was
0.28 (95% CI 0.09–0.47) higher (P = 0.004) for the oﬀspring
of diabetic women compared to controls born to nondiabetic
women [19].
Oﬀspring of diabetic women have also been shown to
have higher fasting glucose levels in adolescence [18], as
well as higher systolic and mean blood pressures than those
born to nondiabetic women [15]. Moreover, oﬀspring of
diabetic women who are born large for gestational age (LGA)
appear to be at an increased risk of adverse cardiometabolic
outcomes. A longitudinal cohort study found significantly
more LGA oﬀspring of diabetic women met the National
Cholesterol Education Program definition of metabolic syn-
drome [33] inmiddle childhood; 15% of oﬀspring of diabetic
women compared to 4.8% in the wider population [14].
Thus, maternal diabetes during pregnancy results in
the development of many recognised cardiovascular risk
factors in their progeny, with an adverse risk profile that
persists into early adulthood in some studies. However, these
longitudinal studies have not followed oﬀspring of diabetic
women for a suﬃcient time-frame to measure rates of adult
cardiovascular disease outcomes such as heart attack and
stroke. Increased rates of hypertension, hyperglycaemia, and
overweight in young adult subjects suggest that this group is
at increased risk of developing cardiac sequelae in later life,
but longitudinal studies that follow the oﬀspring of diabetic
women into middle and older age are essential to quantify
the clinical burden.
5. Methodological Limitation of
Current Research
Investigating the link between in utero exposure to diabetes
mellitus and oﬀspring cardiovascular outcomes is compli-
cated by the long latency of disease onset, the uncertain
significance of intermediate biological measurements (e.g.,
aortic intima-media thickness), and the multitude of con-
founding factors that may influence the risk of cardiovascular
disease at diﬀerent points in an individual’s life course.
The confounding eﬀects of other conditions linked to
maternal diabetes during pregnancy also need to be carefully
considered. Of primary importance, maternal obesity is a
significant risk factor for the development of gestational
diabetes [34] and can be directly linked to adverse infant
outcomes [35]. The increased cardiovascular risk conferred
on the oﬀspring of diabetic women may largely be due to
maternal overweight during pregnancy and not the diabetes
per se. The eﬀect of maternal diabetes on oﬀspring BMI is
partly attenuated in studies that adjust for pre-pregnancy
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BMI, with oﬀspring BMI only 0.07 higher in one meta-
analysis (95% CI −0.15–0.28; P = 0.54) [19]. A prospec-
tive longitudinal cohort study with over 4000 participants
examined the relationship between pre-pregnancy BMI,
gestational diabetes, and the BMI of oﬀspring at age 16.
It demonstrated maternal pre-pregnancy overweight was an
independent risk factor for oﬀspring overweight at age 16
years. The risks were highest in oﬀspring with concomitant
prenatal exposure to GDM, whereas the risks associated with
GDM alone were relatively modest. Thus part of the adverse
eﬀect of maternal diabetes on oﬀspring health appears to
be accounted for by higher maternal obesity rates amongst
diabetic women. There is a need for well-designed studies to
examine the eﬀects of both pathologies and their impact on
oﬀspring cardiovascular health [19].
Diabetes mellitus is not a homogenous disease process—
T1DM, T2DM, and GDM result in exposure to dysglycaemia
at diﬀerent times during fetal development and hence
should be studied and reported separately. Study designs
also need to consider the degree of glycaemic control during
pregnancy, as fetal outcomes will diﬀer depending on the
degree of exposure to hyperglycaemia. The optimal means
of determining antenatal glycaemic control is uncertain.
Glycosylated haemoglobin (HbA1c) can provide a crude
measure of long-term control whilst neonatal cord c-peptide
can provide a measure of the fetal insulin response reflecting
the degree of fetal exposure to hyperglycaemia [36].
Finally, mothers and children share postnatal lifestyle
factors that significantly influence the health of the oﬀspring.
In an attempt to isolate the eﬀects of the intrauterine envi-
ronment and greatly decrease the time and cost associated
with longitudinal studies, surrogate imaging markers of
atherosclerosis have been developed and validated. These
can be utilised in the neonatal period to provide an early
cardiovascular risk assessment.
6. Isolating the Contribution of the
Intrauterine Environment—Assessing
Neonatal Vasculature
Maternal diabetes during pregnancy is known to aﬀect infant
vasculature. As early as 1980 Asmussen studied the umbilical
vessels of infants born to women with T1DM. The umbilical
vessels showed pathological changes in keeping with early
atherosclerosis, including focal intimal thickening and glyco-
gen accumulations in the cells of the intima and the media
[37]. Here we summarise some of the imaging modalities
available to noninvasively assess cardiovascular health.
7. Carotid Intima-Media Thickness
Carotid intima-media thickness (cIMT) is a noninvasive
measure of the thickness of the intima and media layers of
the carotid arterial wall. In the absence of atherosclerotic
plaque, B-mode ultrasound displays the vascular wall as a
regular pattern that correlates with anatomical layers. The
intima-media portion of this pattern is represented by the
area of tissue starting at the luminal edge of the artery
and ending at the boundary between the media and the
adventitia. This interface is well depicted by ultrasound [38].
Carotid intima-media thickness correlates with the degree of
atherosclerosis seen in the carotid artery at autopsy [39] and
with findings at coronary angiography [40]. Increased cIMT
is a strong predictor of future cardiovascular events in adults
[41]. Carotid intima-media thickness is well established as
a surrogate end point in clinical trials assessing the eﬀects
of antihypertensive and lipid lowering drugs, as it allows
evaluation of changes over time [42–44].
Carotid intima-media thickness can be performed in
the paediatric population and has been studied extensively
in children and young adults with known risk factors for
cardiovascular disease. Increased cIMT compared to controls
is observed in children who are overweight [45], those with
familial hypercholesterolaemia [46], Kawasaki disease [47],
as well as in hypertensive children [48]. A trend towards
a decrease in cIMT over time has been reported in a
therapeutic trial of statin therapy in children with familial
hypercholesterolaemia [49].
Ultrasound assessment of cardiovascular risk markers in
childhood has many benefits. Ultrasound involves no radia-
tion, is noninvasive, and is relatively inexpensive. However,
if we wish to isolate and measure the impact of intrauterine
exposure to hyperglycaemia, ultrasound measurements need
to be performed in the neonatal period. Carotid intima-
media thickness measurements require the subject to lie
supine and remain still whilst an ultrasound probe is
positioned over the carotid and measurements are taken at
multiple angles [50]. Whilst some studies have successfully
collected cIMT measurements in children as young as two
years of age [51], measurements are logistically impossible in
neonates, in part because they do not have readily accessible
necks.
8. Aortic Intima-Media Thickness
In neonates, the carotid artery is not accessible for ultrasound
scanning; however it is possible to measure the intima-
media thickness of the neonatal aorta (aortic intima-media
thickness, aIMT).
Atherosclerotic lesions develop in the aorta before they
occur in the carotid; hence measuring aIMT may be not
only more feasible but also a more sensitive indicator
of early atherosclerosis than cIMT in neonates [52]. The
Muscatine oﬀspring study looked at both aIMT and cIMT
measurements in 635 participants aged 11–34. Both aIMT
and cIMT were associated with cardiovascular risk factors,
and in younger participants aIMT gave information beyond
that obtained from cIMT alone [52]. In particular, the aIMT
was more discriminating than cIMT in high-risk subjects
with diabetes and hyperlipidaemia.
Risk factors for increased aIMT have been investigated
in several paediatric studies. Aortic intima-media thickness
has been found to be significantly increased in infants with
intrauterine growth restriction [53] and those exposed
to maternal smoking in utero [54]. It is also significantly
increased in children with current hypercholesterolaemia
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and T1DM when compared to controls without these
illnesses [55].
Only one study has investigated the contribution of
maternal diabetes to oﬀspring aIMT during the neonatal
period. Increased aIMT has been demonstrated in macro-
somic oﬀspring of diabetic women when compared to
controls. Macrosomic oﬀspring of diabetic women had
increased aIMT and abnormal lipid profile when compared
to macrosomic oﬀspring of controls (when adjusted for birth
weight) [56]. This suggests that oﬀspring of diabetic women
are not at an increased risk simply due to their size, but due
to another as yet undefined mechanism inherent in diabetic
pregnancies.
More information is needed regarding the normal and
pathological range of aIMT in neonates; however aIMT
has great promise as a non-invasive, relatively inexpensive,
reproducible tool to quantify cardiovascular risk in infants.
Further research in this area is warranted: future studies
should assess women with T1DM, T2DM, and GDM sepa-
rately. Maternal pre-pregnancy BMI and pregnancy weight
gain should be reported, as well as degree of glycaemic
control throughout pregnancy. Ideally comparisons should
be made with both normal weight and overweight maternal
control groups. The use of siblings, whose pregnancies were
not complicated by hyperglycaemia, will be important in
teasing out nongenomic factors. Finally, it would be of great
interest to determine if increased aIMT measurements in
this group persist into childhood and adulthood or whether
postnatal influences attenuate these findings over time.
9. Retinal Photography
Retinal photography is another promising option to assess
the vasculature of oﬀspring of diabetic women in the neona-
tal period. Atherosclerosis is a systemic vascular disease that
can cause abnormalities throughout the body. Imaging of the
retinal vessels has been used in many patient populations as
the retina provides a unique opportunity to directly visualise
a vascular bed [57]. Retinal changes may reflect preclinical
changes in the coronary and cerebral microcirculations.
In adults, retinal vessel atherosclerosis is highly correlated
with atherosclerotic changes of coronary arteries seen at
angiography [58]. Cohort studies of asymptomatic adult
subjects demonstrated that smaller arterioles and larger
venules predicted an increased risk of subsequent coronary
heart disease mortality [59].
In the research setting, retinal photography has been
successfully performed in a large number of children,
including in adolescents with T2DM [60] and a cohort of
over 700 schoolchildren aged 7 to 9 years in a cross-sectional
study [61]. Some studies have included children as young
as four years old [62], but large-scale trials have not been
performed in neonates. However, the technology is already
in place in many countries to image the retina of neonates.
Premature infants frequently require routine examinations
of their retinas to screen for retinopathy of prematurity,
and many centres use digital retinal photography as part
of this screening process. Retinal vessel photography is a
validated research tool and may be an ideal investigation
to apply to oﬀspring of diabetic women in the neonatal
period to further assess their cardiovascular risk. Potential
downsides include infant discomfort [63] and lack of access
to specialised equipment and operators to produce images of
suﬃcient quality to allow robust analyses of retinal vessels.
10. Echocardiography
Echocardiography has been used extensively in the neonatal
period to assess the eﬀect of in utero exposure to maternal
diabetes. The increased rate of structural heart defects in oﬀ-
spring of diabetic women is clearly established [64] and will
not be discussed further in this paper. Maternal diabetes is a
significant risk factor for the development of hypertrophic
cardiomyopathy (HCM) in the neonate, observed in 38%
of cases in one series [64]. These changes appear to resolve
during the first year of life [65], but there is limited evidence
regarding the impact of maternal diabetes on oﬀspring
cardiac function in the long-term. One echocardiographic
study demonstrated no diﬀerence in cardiac dimensions or
function between children born to women with T1DM and
controls in mid-childhood [66]. However, the study included
only three children who experienced neonatal HCM; thus a
better-powered study may have been more informative. The
long term consequences of neonatal HCM remain uncertain.
Echocardiography is a useful, non-invasive research
tool that can be used across the lifespan. Further studies
tracking larger numbers of oﬀspring of diabetic women into
childhood and beyond may further our understanding of the
impact of maternal diabetes on the long-term cardiovascular
health of their oﬀspring.
11. Electrocardiography
Electrocardiography (ECG) can also be used to assess the
cardiovascular health of the oﬀspring of diabetic women.
Among adults, diabetes mellitus is associated with ECG
abnormalities indicative of impaired electrogenesis. A lon-
gitudinal study of adult T1DM patients over a seven-
year period showed that 18.7% of participants developed a
prolonged corrected QT interval (QTc) over the course of the
study [76]. This is potentially significant as QTc is predictive
of all cause cardiovascular mortality, even in apparently
healthy and nondiabetic individuals [77].
Animal models have demonstrated an association
between diabetes mellitus and abnormal cardiac electrophys-
iology. In a diabetic rat model, isolated ex vivo hearts were
placed under stress (using gap junction uncoupler heptanol
or elevated potassium to reduce cell excitability); there was
a significantly greater slowing of impulse propagation in
diabetic hearts than in controls [78]. There is also impaired
intercellular communication in trabeculae isolated from the
ventricles of diabetic rat hearts compared to nondiabetic
controls [79]. These data suggest that the diabetic heart
has a substantially smaller conduction reserve than the
nondiabetic heart, rendering it vulnerable to conduction
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Table 1: Assessment of cardiovascular health in prepubescent oﬀspring of diabetic women.
Modality Age Method Limitations
Evidence in children of
diabetics
Blood pressure
From birth,
but diﬃcult
to perform
reliably in
infants
Oscillometric (most common) or
auscultatory measurement of blood
pressure with sphygmomanometer.
Subjects need to be completely relaxed,
in a uniform position (e.g., sitting) and
uniform site of measurement (e.g., right
arm).
Cuﬀ needs to be correctly sized.
Minimum of two measurements.
May be diﬃcult to obtain
“resting” blood pressure in
young children—as the cuﬀs
can be uncomfortable and
cause distress.
Large cohort study of school
children looked at subgroup
of oﬀspring of diabetic
women and found no
diﬀerence in systolic or
diastolic blood pressure [67].
Other studies have
demonstrated higher systolic
and mean blood pressures in
oﬀspring of diabetic women
than controls [15].
Electrocardiography
(ECG)
All
ages—can
be
performed
in utero
Leads are placed on chest wall in
standard locations. Electrical impulses
are transmitted to ECG machine and
ECG tracing is produced.
ECG most accurate if patient
remains still during
reading—can be diﬃcult for
young children.
Requires the subject to be at
a comparable level of
exertion (e.g., at rest).
Infants of diabetic women
demonstrate leftward axis
deviation when compared to
controls [68]. Fetuses of
diabetic women demonstrate
significantly more ST
depression on fetal ECG
during labour than infants of
control women [69].
Vessel structure
Carotid artery
intima-media
thickness (cIMT)
From 5
years of age
High-resolution B-mode
ultrasonography. Measure thickness of
intima-media of posterior wall of carotid.
In adults correlates to atherosclerosis at
autopsy [39] and coronary angiography
[40] as well as predictor of future
cardiovascular events [41].
Need to be able to access the
neck over the carotid area
[50].
Has been used in children
>5 years old [70], technically
diﬃcult in younger children.
Skilled operator required.
Although cIMT has been used
to follow up mothers with
gestational diabetes [71, 72],
currently no studies in
oﬀspring of diabetic women.
Aortic intima-media
thickness (aIMT)
From
birth/in
utero
High-resolution B-mode
ultrasonography. Measure thickness of
intima-media of posterior wall of
abdominal aorta.
Good correlation with cIMT [55].
Most easily performed on
the settled infant/child.
Yet to be correlated with
long-term disease risk.
Increased aIMT found in
oﬀspring of diabetic women
(additive eﬀect with maternal
obesity) [10].
Retinal vessel imaging
From birth
(pupillary
dilatation
required)
and from
school age
without
dilatation
45◦ digital retinal photography
following pupil dilatation [62].
Method has been used to evaluate
retinopathy of prematurity in neonates.
Requires pupil dilation.
May be uncomfortable for
infants [63].
No current studies in
oﬀspring of diabetic women.
Two large unselected cohort
studies in children underway
in Australia and Singapore.
Endothelial function
Pulse wave velocity
(PWV)
From 5
years of age
Peripheral pulse wave form measured at
the radial artery, carotid and femoral
artery in order to calculate central aortic
pressure as well as carotid-femoral pulse
wave velocity.
Would be limited by
cooperation and physical
access in younger children.
One study looking at oﬀspring
of diabetic women at ∼15
years found positive
correlation between GDM
(umbilical cord c-peptide,
insulin) and arterial stiﬀness
[73].
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Table 1: Continued.
Modality Age Method Limitations
Evidence in children of
diabetics
Brachial artery
dilatation
Older
children
(∼10 years
and above)
B-mode ultrasound—assessing dilator
response of brachial artery to endothelial
dependent and nondependent factors.
First stage—pneumatic cuﬀ suprasystolic
for 5 minutes then deflates and measures
brachial dilatation.
Second stage—GTN given orally and
measures brachial dilatation.
Poorly tolerated by children
(both time taken and cuﬀ
discomfort).
Invasive (administering
GTN orally).
Need to be fasting.
Studies in women with
GDM—one study found no
change [74].
No studies in oﬀspring of
diabetic women.
Endopat
Older
children
(∼10 years
and above)
Similar to brachial artery dilatation.
Endopat apparatus on finger—measuring
pulse wave. Measured at rest, then with
pneumatic cuﬀ inflated to 60mmHg or
200mmHg for one minute, then
measured following deflation [75].
Takes 15 minutes.
Need to be fasting.
May be diﬃcult to tolerate
in children (especially
pneumatic cuﬀ over systolic
BP).
Expensive.
No data in either diabetic
women or their oﬀspring.
Cardiac function
Echocardiography
From
birth/in
utero
2-dimensional, M mode and Doppler
ultrasonography of the heart.
Requires specialist paediatric
echocardiographer/
sonographer with
experience in interpreting
paediatric findings.
Increased risk of HCM in
oﬀspring of diabetic women
[64].
Resolution of changes by first
year of life [65].
No studies following oﬀspring
of diabetic women into
adulthood.
disturbances and arrhythmias caused by physiological and
pathological challenges such as ischaemia or exercise [78].
Transient disturbances in glucose metabolism may also
result in quantifiable ECG changes. In healthy adults,
hyperinsulinaemia-induced hypoglycaemia can prolong the
QTc interval and decrease T-wave area and amplitude [80].
This ECG-based assessment may be of particular relevance
in studies of the oﬀspring of diabetic women during the
neonatal period, as these infants are at a higher risk of
hyperinsulinaemia-induced hypoglycaemia than the general
population.
Studies examining ECG changes in the oﬀspring of
diabetic women are, however, limited. Bacharova et al.
performed ECGs on 109 oﬀspring of diabetic women as well
as 81 control infants. A modest but statistically significant
leftward shift of electrical axis was observed in the oﬀspring
of diabetic women [68]. Infants of diabetic women also
appear to be less able physiologically to respond to the stress
of labour; on fetal ECG, these infants were more likely to
demonstrate ST depression than infants of control women
[69].
Electrocardiography is a non-invasive, inexpensive, and
very well-established method of assessing cardiovascular
health. ECG is therefore a useful potential adjunct inves-
tigation to assess the cardiovascular health of infants of
diabetic mothers. Future research should aim to recruit
large cohorts of infants born to diabetic women and follow
them through childhood and into adulthood to determine
the eﬀect of intrauterine exposure to hyperglycaemia on
future cardiovascular health. Electrocardiographs should be
reviewed looking for signs that are seen in diabetic patients—
sinus tachycardia, long QTc, QT dispersion, changes in
heart rate variability, ST-T changes, and left ventricular
hypertrophy [81].
12. Other Modalities
A number of other modalities, both conventional and novel,
can be used in older oﬀspring of diabetic women. These
and the modalities discussed previously are summarised in
Table 1.
13. Clinical Relevance and Future Directions
Exposure to diabetes during pregnancy has diverse negative
eﬀects on the cardiovascular health of the developing child.
Some of these eﬀects may be related to coexisting maternal
overweight/obesity and possibly dyslipidaemia, which are
often correlated with diabetes. The degree of glycaemic
control during pregnancy and the timing of the onset of
hyperglycaemia are likely to influence the impact on fetal
development.
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Longitudinal studies have demonstrated that oﬀspring
of diabetic women are at an increased risk of developing
a number of cardiovascular risk factors including hyper-
tension, impaired glucose tolerance, dyslipidaemia, and
overweight/obesity. Some of these negative health outcomes
may be due to genetic or postnatal lifestyle exposures, but
the evidence to date indicates that in utero exposure to
hyperglycaemia does play a significant role.
Novel imaging techniques applied during the newborn
period will allow a more precise assessment of the eﬀect of
the intrauterine environment. Further research is needed in
this domain to determine how aIMT findings in neonates
translate into cardiovascular disease in adults. Oﬀspring of
diabetic womenmay need to be considered a high-risk group
for more intensive cardiovascular monitoring in the future.
Importantly, in the face of the obesity “epidemic” and rising
rates of diabetes in pregnancy, increased focus on initiating
disease prevention in utero may have dramatic eﬀects on
population-level adult cardiovascular health outcomes.
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